Literature DB >> 19806151

Oligoarticular and polyarticular JIA: epidemiology and pathogenesis.

Claudia Macaubas1, Khoa Nguyen, Diana Milojevic, Jane L Park, Elizabeth D Mellins.   

Abstract

Juvenile idiopathic arthritis (JIA) refers to a group of chronic childhood arthropathies of unknown etiology, currently classified into subtypes primarily on the basis of clinical features. Research has focused on the hypothesis that these subtypes arise through distinct etiologic pathways. In this Review, we discuss four subtypes of JIA: persistent oligoarticular, extended oligoarticular, rheumatoid-factor-positive polyarticular and rheumatoid-factor-negative polyarticular. These subtypes differ in prevalence between ethnic groups and are associated with different HLA alleles. Non-HLA genetic risk factors have also been identified, some of which reveal further molecular differences between these subtypes, while others suggest mechanistic overlap. Investigations of immunophenotypes also provide insights into subtype differences: adaptive immunity seems to have a prominent role in both polyarticular and oligoarticular JIA, and the more-limited arthritis observed in persistent oligoarticular JIA as compared with extended oligoarticular JIA may reflect more-potent immunoregulatory T-cell activity in the former. Tumor necrosis factor seems to be a key mediator of both polyarticular and oligoarticular JIA, especially in the extended oligoarticular subtype, although elevated levels of other cytokines are also observed. Limited data on monocytes, dendritic cells, B cells, natural killer T cells and neutrophils suggest that the contributions of these cells differ across subtypes of JIA. Within each subtype, however, common pathways seem to drive joint damage.

Entities:  

Mesh:

Year:  2009        PMID: 19806151      PMCID: PMC4159935          DOI: 10.1038/nrrheum.2009.209

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  109 in total

1.  A polymorphic variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis.

Authors:  R Marciano; F Giacopelli; M T Divizia; M Gattorno; E Felici; A Pistorio; A Martini; R Ravazzolo; P Picco
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

Review 2.  Juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Alberto Martini
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

3.  Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.

Authors:  Wilco de Jager; Esther P A H Hoppenreijs; Nico M Wulffraat; Lucy R Wedderburn; Wietse Kuis; Berent J Prakken
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

4.  Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker?

Authors:  P Spelling; E Bonfá; V F Caparbo; R M R Pereira
Journal:  Scand J Rheumatol       Date:  2008 Nov-Dec       Impact factor: 3.641

5.  Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis.

Authors:  L R Wedderburn; N Robinson; A Patel; H Varsani; P Woo
Journal:  Arthritis Rheum       Date:  2000-04

6.  Clinical characteristics of juvenile rheumatoid arthritis in Taiwan.

Authors:  C J Wu; J L Huang; M H Yang; D C Yan; L S Ou; H H Ho
Journal:  J Microbiol Immunol Infect       Date:  2001-09       Impact factor: 4.399

7.  One hundred and seventy cases of childhood-onset rheumatological disease in Singapore.

Authors:  Y See; E T Koh; M L Boey
Journal:  Ann Acad Med Singapore       Date:  1998-07       Impact factor: 2.473

8.  A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage.

Authors:  Susan D Thompson; Marta B Moroldo; Laura Guyer; Mary Ryan; Esther M Tombragel; Edith S Shear; Sampath Prahalad; Marc Sudman; Mehdi A Keddache; W Mark Brown; Edward H Giannini; Carl D Langefeld; Stephen S Rich; William C Nichols; David N Glass
Journal:  Arthritis Rheum       Date:  2004-09

9.  Quantitative alterations of CD8+ T cells in juvenile idiopathic arthritis patients in remission.

Authors:  Martina Prelog; Nora Schwarzenbrunner; Elisabeth Tengg; Michaela Sailer-Höck; Hannelore Kern; Lothar Bernd Zimmerhackl; Juergen Brunner
Journal:  Clin Rheumatol       Date:  2008-12-18       Impact factor: 2.980

10.  CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis.

Authors:  Ismé M de Kleer; Lucy R Wedderburn; Leonie S Taams; Alka Patel; Hemlata Varsani; Mark Klein; Wilco de Jager; Gisela Pugayung; Francesca Giannoni; Ger Rijkers; Salvatore Albani; Wietse Kuis; Berent Prakken
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  36 in total

Review 1.  What do cytokine profiles tell us about subsets of juvenile idiopathic arthritis?

Authors:  Rolando Cimaz; Davide Moretti; Ilaria Pagnini; Achille Marino; Luca Cantarini; Gabriele Simonini
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 2.  Classification of juvenile spondyloarthritis: Enthesitis-related arthritis and beyond.

Authors:  Robert A Colbert
Journal:  Nat Rev Rheumatol       Date:  2010-07-06       Impact factor: 20.543

Review 3.  Juvenile idiopathic arthritis-associated uveitis.

Authors:  Ying Qian; Nisha R Acharya
Journal:  Curr Opin Ophthalmol       Date:  2010-11       Impact factor: 3.761

4.  Alternative activation in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Khoa D Nguyen; Ariana Peck; Julia Buckingham; Chetan Deshpande; Elizabeth Wong; Heather C Alexander; Sheng-Yung Chang; Ann Begovich; Yue Sun; Jane L Park; Kuang-Hung Pan; Richard Lin; Chih-Jian Lih; Erin M Augustine; Carolyn Phillips; Andreas V Hadjinicolaou; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2011-12-28       Impact factor: 3.969

Review 5.  Emerging role of antioxidants in the protection of uveitis complications.

Authors:  U C S Yadav; N M Kalariya; K V Ramana
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

6.  Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states.

Authors:  Claudia Macaubas; Khoa Nguyen; Chetan Deshpande; Carolyn Phillips; Ariana Peck; Tzielan Lee; Jane L Park; Christy Sandborg; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2009-10-29       Impact factor: 3.969

7.  Epipolymorphisms associated with the clinical outcome of autoimmune arthritis affect CD4+ T cell activation pathways.

Authors:  Roberto Spreafico; Maura Rossetti; John W Whitaker; Wei Wang; Daniel J Lovell; Salvatore Albani
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

Review 8.  The genetics of juvenile idiopathic arthritis: what is new in 2010?

Authors:  Sheila Angeles-Han; Sampath Prahalad
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

9.  Altered signaling in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Elizabeth Wong; Yujuan Zhang; Khoa D Nguyen; Justin Lee; Diana Milojevic; Susan Shenoi; Anne M Stevens; Norman Ilowite; Vivian Saper; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2015-12-31       Impact factor: 3.969

10.  Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis.

Authors:  Jeffrey A Dvergsten; Robert G Mueller; Patricia Griffin; Sameem Abedin; Allyson Pishko; Joshua J Michel; Margalit E Rosenkranz; Ann M Reed; Daniel A Kietz; Abbe N Vallejo
Journal:  Arthritis Rheum       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.